CN117503626B - 植物来源的防晒增效组合物、防晒产品、制备方法和应用 - Google Patents
植物来源的防晒增效组合物、防晒产品、制备方法和应用 Download PDFInfo
- Publication number
- CN117503626B CN117503626B CN202311496013.8A CN202311496013A CN117503626B CN 117503626 B CN117503626 B CN 117503626B CN 202311496013 A CN202311496013 A CN 202311496013A CN 117503626 B CN117503626 B CN 117503626B
- Authority
- CN
- China
- Prior art keywords
- parts
- sun
- screening
- extract
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012216 screening Methods 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 230000002195 synergetic effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 40
- 241000736131 Sphingomonas Species 0.000 claims abstract description 29
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 26
- 238000000855 fermentation Methods 0.000 claims abstract description 26
- 230000004151 fermentation Effects 0.000 claims abstract description 26
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 25
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940036350 bisabolol Drugs 0.000 claims abstract description 23
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003995 emulsifying agent Substances 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- -1 diethylcarbamoylhexyl benzoate Chemical compound 0.000 claims description 17
- 239000003906 humectant Substances 0.000 claims description 17
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 16
- 239000003974 emollient agent Substances 0.000 claims description 15
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 241000220317 Rosa Species 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 10
- 230000002335 preservative effect Effects 0.000 claims description 10
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 8
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 229960004881 homosalate Drugs 0.000 claims description 8
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 8
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 7
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 7
- SRVSYCCHRDXMMS-UHFFFAOYSA-N dodecan-5-yl 2-hydroxybenzoate Chemical compound CCCCCCCC(CCCC)OC(=O)C1=CC=CC=C1O SRVSYCCHRDXMMS-UHFFFAOYSA-N 0.000 claims description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 7
- 239000004408 titanium dioxide Substances 0.000 claims description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 6
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 6
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 6
- 229960000601 octocrylene Drugs 0.000 claims description 6
- 239000001540 sodium lactate Substances 0.000 claims description 6
- 229940005581 sodium lactate Drugs 0.000 claims description 6
- 235000011088 sodium lactate Nutrition 0.000 claims description 6
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 claims description 5
- 229960005150 glycerol Drugs 0.000 claims description 5
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 4
- 229960000655 ensulizole Drugs 0.000 claims description 4
- 229940100460 peg-100 stearate Drugs 0.000 claims description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims 1
- 229940113124 polysorbate 60 Drugs 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 6
- 230000001914 calming effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 29
- 239000000516 sunscreening agent Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 23
- 230000000475 sunscreen effect Effects 0.000 description 23
- 230000037072 sun protection Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 241000196324 Embryophyta Species 0.000 description 15
- 241000209094 Oryza Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- 230000006378 damage Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 235000002548 Cistus Nutrition 0.000 description 5
- 241000984090 Cistus Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010042496 Sunburn Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000010779 crude oil Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 206010040914 Skin reaction Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229930007927 cymene Natural products 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Benzoesaeure-n-hexylester Natural products CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001668 ameliorated effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940116852 myricetin Drugs 0.000 description 2
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 2
- 235000007743 myricetin Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229960005196 titanium dioxide Drugs 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- YKNCPXOFSKBINA-UHFFFAOYSA-N (2-hydroxy-4-methoxyphenyl)-phenylmethanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1.OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 YKNCPXOFSKBINA-UHFFFAOYSA-N 0.000 description 1
- AKUPYGILGNUOIG-UHFFFAOYSA-N 5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1 AKUPYGILGNUOIG-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- SWIWTAJTJOYCTB-NMYXBGBTSA-N Campesteryl ferulate Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2CC3=CC[C@H]4[C@@H]5CC[C@@H]([C@@]5(C)CC[C@@H]4[C@@]3(C)CC2)[C@H](C)CC[C@@H](C)C(C)C)=C1 SWIWTAJTJOYCTB-NMYXBGBTSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000005238 Cistus monspeliensis Nutrition 0.000 description 1
- 241000372914 Cistus monspeliensis Species 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- QVZGAIWUSYVGBJ-UHFFFAOYSA-N Cycloartenyl ferulate Natural products CCC12CCC3(C)C(C(C)CCC=C(C)C)CCC3(C)C1CCC(C1(C)C)C2CCC1OC(=O)C=CC1=CC=C(O)C(OC)=C1 QVZGAIWUSYVGBJ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- ROUSJNZGMHNWOS-OJJOFZOASA-N Feruloyl-beta-sitosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)C(=O)\C=C\C1=CC=C(O)C(OC)=C1 ROUSJNZGMHNWOS-OJJOFZOASA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- JBSUVXVGZSMGDJ-YVMHCORFSA-N Oryzanol C Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC(=C)C(C)C)(C)C)=C1 JBSUVXVGZSMGDJ-YVMHCORFSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000003373 basosquamous carcinoma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- FODTZLFLDFKIQH-UHFFFAOYSA-N cycloartenol trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-UHFFFAOYSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
本发明提供了植物来源的防晒增效组合物、防晒产品、制备方法和应用，包括以下重量份数的组分：谷维素0.001‑1份、聚繖岩蔷薇提取物0.001‑0.5份、鞘氨醇单胞菌发酵产物提取物0.001‑0.5份和红没药醇0.001‑0.5份。本发明还提供了含有防晒增效组合物的防晒产品及其制备方法，增效防晒力的同时，可以起到镇静舒缓晒后肌肤、修护减轻泛红肌肤的作用。本发明还提供了所述的防晒增效组合物在化妆品中的应用。
Description
技术领域
本发明属于化妆品技术领域，具体涉及植物来源的防晒增效组合物、防晒产品、制备方法和应用。
背景技术
紫外线(UV)对皮肤的伤害可导致晒伤、皮肤衰老和增加患皮肤癌风险等。紫外线照射皮肤会引起晒伤，表现为皮肤红、肿、痛，严重时还可出现水泡、脱皮等症状。晒伤不仅会给肌肤带来不适，还会导致长期的皮肤损伤和色素沉着。紫外线是导致皮肤早衰的主要因素之一。长期暴露在紫外线下，会破坏皮肤中的胶原蛋白和弹力纤维，导致皮肤松弛、皱纹增多、失去弹性等，使肌肤看起来老化。长期暴露在紫外线下，特别是紫外线B(UVB)会增加患皮肤癌的风险。UVA在紫外线中含量比重高，渗透力强，渗入真皮层，造成难以恢复的伤害及皮肤衰老，同时UVA又具有隐蔽性，它能穿透玻璃进入室内、车内，随季节变化很小，因此更具有欺骗性，使你在不知觉中受到伤害。常见的皮肤癌类型包括基底细胞癌、鳞状细胞癌和黑色素瘤。某些人可能对紫外线过敏，出现光敏性皮炎、太阳性皮炎等光敏性皮肤病。这些疾病会在阳光暴晒后引起皮肤红肿、瘙痒、水泡等不适。为了保护皮肤免受紫外线的伤害，需要采取一系列防晒措施，如使用防晒产品。
防晒产品可以保护皮肤免受紫外线辐射的损伤。虽然防晒产品对于保护皮肤免受紫外线伤害非常重要，但也存在一些缺点。某些防晒产品中含有化学成分，如氧苯酮(Oxybenzone)和雷贝拉索(Retinyl Palmitate)，有些人可能对这些成分过敏。防晒产品可能会给皮肤留下油腻感，特别是那些含有较多油脂成分的产品。此外，某些防晒产品可能在皮肤上留下白色或粘腻的残留物，使皮肤看起来不够自然。而从植物或发酵物中筛选的天然防晒剂及增效剂因具有天然、致敏低等特点、兼有保湿、抗氧化、美白等多种功效，近年来被添加到现有配方中以减少传统防晒剂的用量而成为研究热点。针对目前国内防晒产品过于强调防晒值而忽略紫外线及环境对人体肌肤伤害的现象，亟需寻找一种能够提高防晒指数，达到高防晒效果，且安全、温和的防晒产品。
发明内容
本发明的目的是提供植物来源的防晒增效组合物、防晒产品及其制备方法和应用，增效防晒力的同时，可以起到镇静舒缓晒后肌肤、修护减轻泛红肌肤的作用。
为了实现上述目的，本发明提供了以下技术方案：
本发明第一方面提供了植物来源的防晒增效组合物，包括以下重量份数的组分：谷维素0.001-1份、聚繖岩蔷薇提取物0.001-0.5份、鞘氨醇单胞菌发酵产物提取物0.001-0.5份和红没药醇0.001-0.5份。
谷维素又称米糠素，存在于谷类植物籽粒中，其含量随稻谷种植的气候条件、稻谷品种及米糠取油的工艺条件不同而略有差异。在籽粒皮层和胚芽中含量为0.3％-0.5％，在毛油中含量为1.8％-3.0％，寒带稻谷米的米糠中谷维素含量高于热带Q0稻谷，高温压榨和溶剂浸出取油，毛油中谷维素的含量比低温压榨高。谷维素主要存在于毛糠油及其油脚中，米糠层中谷维素的含量为0.3％-0.5％。谷维素是以环木菠萝醇类为主的阿魏酸酯和甾醇类的阿魏酸酯所组成的一种天然混合物，目前已检测鉴定的谷维素成分有十几种，主要有环木菠萝烯醇阿魏酸酯、环木菠萝醇阿魏酸酯、24–亚甲基环木菠萝醇阿魏酸酯、菜油甾醇阿魏酸酯、β–谷甾醇阿魏酸酯等。
岩蔷薇，一种能在火烧后恢复生长的植物，产于欧洲南部和北非(摩洛哥、葡萄牙、法国)的地中海森林、林地和灌木丛。这种植物的叶子具有保护性的毛状体，并富含一种天然的抗氧化分子:杨梅素糖苷(Myricetin glycosides)，可以保护皮肤与阳光引起的损伤，加速表皮更新，拯救皮肤与多重光暴露。
鞘氨醇单胞菌分布常广泛，从陆地到河流海洋，从地层深处到空气中，从南极到赤道附近，都遍布着鞘氨醇单胞菌属的成员。能够耐受高度贫营养环境和恶劣环境,它们有着特殊的代谢调控机制以适应多变的环境(尤其是营养物缺乏的环境)；能够利用的底物广泛，从多环芳烃类化合物、聚乙烯醇等高聚物到简单无机物N2，都能利用。从土壤中植物的根际分离出来的鞘氨醇单胞菌，它们可以在植物根际分泌糖类营养物，能显著提高处理植株对盐胁迫的抗性，促进植物吸收。鞘氨醇单胞菌发酵产物提取物鞘氨醇单胞菌发酵产物中含有多种活性成分，鞘氨醇是鞘氨醇单胞菌发酵产物最重要的活性成分之一，具有保湿、滋润和抗菌的功效，并可以改善皮肤屏障功能。鞘氨醇单胞菌发酵产物中的多糖具有保湿、舒缓和抗炎的作用，能够增强肌肤的保水能力，减轻敏感和红肿。氨基酸是鞘氨醇单胞菌发酵产物中的重要成分之一，具有保湿、滋养和修复肌肤的功效。它们可以促进胶原蛋白和弹力纤维的生成，使肌肤更紧致和光滑。鞘氨醇单胞菌发酵产物中的抗氧化物质可以中和自由基，减少氧化损伤，保护肌肤免受环境污染和紫外线辐射的伤害。生物活性肽也是鞘氨醇单胞菌发酵产物中的活性成分，具有抗菌、抗炎和抗衰老的作用。它们可以促进胶原蛋白合成，提供皮肤弹性和紧致度。
红没药醇，CAS：515-69-5，结构图：
是一种天然的活性成分，也被称为沉香酚。红没药醇具有多种生物活性，尤其在抗氧化和抗炎方面表现出色。红没药醇具有强大的抗氧化能力，可以中和自由基并减少氧化损伤，保护细胞免受环境侵害和氧化应激的影响。红没药醇显示出显著的抗炎特性，可以抑制炎症因子的释放和炎症过程的发展，有助于缓解炎症相关问题。研究显示红没药醇对某些细菌和真菌具有抑制作用。目前α-红没药醇可分为合成来源和天然来源。天然来源的α-红没药醇一般提取自巴西灌木(Candeia)，但受限于原料稀缺性。本发明所用的红没药醇可用发酵法生产、以植物来源糖为碳源得到，不受原料稀缺性局限。
申请人意外地发现，将植物来源的谷维素、聚繖岩蔷薇(CISTUS MONSPELIENSIS)提取物、鞘氨醇单胞菌(SPHINGOMONAS)发酵产物提取物进行复配，添加到防晒产品中，具有增效防晒的作用，猜测原因可能在于，谷维素和聚繖岩蔷薇提取物，可以协同吸收紫外光，抵御在紫外及蓝光照射下的肌肤损伤，增效防晒；发酵分离出的鞘氨醇单胞菌胞外多糖对透明质酸酶的活性具有良好的抑制作用，鞘氨醇单胞菌发酵产物提取物和红没药醇，可以协同舒缓光照引发的泛红、皮损，修复肌肤。
进一步地，谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇的重量比为1：0.02-5：0.2-10.0：1-20.0。
发明人意外发现，本发明提供的此组合物会减少防晒产品产品引起过敏，比如某含一定量酒精的防晒喷雾加了该组合物斑贴无异常。防晒产品在使用时，通常需要补涂，尤其在户外活动中更是频繁补涂，以保持其有效性，这对于那些经常外出的人来说可能会有些不便，还会增加使用成本。发明人意外发现当所述谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇的重量比为1：0.02-0.5：0.2-5.0：1-20.0时，可以延长防晒组合物的防晒时间，减少涂补次数。
谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇均为市售产品。
本发明第二方面提供了一种防晒产品，由以下重量份的组分组成，按100重量份计，包括所述的防晒增效组合物0.5-5份、奥克立林1-5份、双-乙基己氧苯酚甲氧苯基三嗪0.5-5份、乙基己基三嗪酮0.5-5份、二乙氨羟苯甲酰基苯甲酸己酯0.5-5份、胡莫柳酯1-10份、苯基苯并咪唑磺酸1-5份、二氧化钛2-10份、润肤剂10-30份、乳化剂0.5-3份、保湿剂1-6份、乙二胺四乙酸二钠0.01-0.3份、香精0.01-0.5份和防腐剂0.1-2份，余量为水。
本发明将谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇复配，作为防晒增效组合物，可以提升产品的防晒效果。
进一步地，所述润肤剂选自鲸蜡基乙基己酸酯、辛酸/癸酸甘油三酯、异十六烷、聚二甲基硅氧烷、C12-15醇苯甲酸酯、聚羟基硬脂酸、丁基辛醇水杨酸酯中的一种或多种。
更进一步地，所述润肤剂为重量比4:3-4:4-6的鲸蜡醇乙基己酸酯、异十六烷、丁基辛醇水杨酸酯复配。
本发明将重量比4:3-4:4-6的鲸蜡醇乙基己酸酯、异十六烷、丁基辛醇水杨酸酯复配作为润肤剂，使防晒产品更易推开。还意外发现改善了防晒产品的抗水成膜性差的问题，但添加润肤剂使防晒产品的储存稳定性不理想，猜测是多种植物来源的成分在体系内同其他化学成分的相容性差。
鲸蜡醇乙基己酸酯，CAS：59130-69-7；异十六烷，CAS：
4390-04-9、丁基辛醇水杨酸酯，CAS:190085-41-7。
进一步地，所述保湿剂选自甘油、丁二醇、透明质酸钠、1,3-丙二醇、乳酸、乳酸钠中的一种或多种。
更进一步地，所述保湿剂为甘油、透明质酸钠和乳酸钠复配。
更进一步地，所述保湿剂为重量比3:0.08:4的甘油、透明质酸钠和乳酸钠复配。
透明质酸钠，分子量1.0×106-1.5×106。
更进一步的，所述乳化剂为水分散乳化剂，包括以下重量份组分：甘油硬脂酸酯1.1份，PEG-100硬脂酸酯0.9份，聚山梨醇酯-601份。本发明通过保湿剂和乳化剂复配，改善了防晒产品的储存稳定性。并且意外发现当保湿剂和乳化剂以一定的比例复配后，制备的防晒产品应用在皮肤有破损的痘痘肌和敏感肌上效果良好，不会产生过敏现象。本发明的防晒产品尤其适用于皮肤有破损的痘痘肌和敏感肌人群。
进一步地，所述防腐剂为：重量比9:1的苯氧乙醇和乙基己基甘油。
进一步地，所述香精可以选自本领域常用的种类。
本发明第三方面提供了一种防晒产品的制备方法，包括以下步骤：
1)室温下将卡波姆、黄原胶、保湿剂、乙二胺四乙酸二钠、水分散乳化剂和水混合，再加热升温至75～85℃分散，保温8～12min，作为A相；
2)将奥克立林、谷维素、双-乙基己氧苯酚甲氧苯基三嗪、乙基己基三嗪酮、二乙氨羟苯甲酰基苯甲酸己酯、胡莫柳酯、二氧化钛、润肤剂和油分散乳化剂混合，加热升温至75～85℃溶解，保温8～12min，作为B相；
3)保温，将B相加入A相中乳化均质均匀，降温至55～60℃，再加入C相，加入pH中和剂，搅拌均匀；
4)搅拌降温至40～45℃，将香精、防腐剂、鞘氨醇单胞菌发酵产物提取物份和红没药醇混合，搅拌均质均匀；陈化过滤后得到所述防晒产品。本发明使用的原料没有特殊说明，均为市售产品。
本发明第四方面提供了所述的防晒增效组合物在制备防晒产品中的应用，所述防晒产品包括水包油或油包水等多种配方体系的防晒乳、防晒露、防晒喷雾、隔离霜、防晒棒。
与现有技术相比，本发明的优点和有益效果为：
1、本发明按照特定质量配比将谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇作为防晒活性组分使用，在吸收紫外线、修复晒伤肌肤方面起到了明显的协同增效作用，防护范围覆盖UVB、UVA蓝光波长区域。本发明的组合物不仅可以通过吸收紫外线来进行光防护，还能清除蓝光诱导下产生的大量活性氧自由基，通过提高皮肤本身的抵抗力和修复力来提高对外界有害光线的抵御能力。
2、当所述谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇的重量比为1：0.02-5：0.2-10.0：1-20.0时，可以延长防晒组合物的防晒时间，减少涂补次数。
3、本发明将谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇复配，作为防晒增效组合物，可以提升防晒产品的防晒效果。
4.本发明将重量比1-4:1:0.1-0.7的鲸蜡醇乙基己酸酯、异十六烷、丁基辛醇水杨酸酯复配作为润肤剂，使防晒产品更易推开。还意外发现改善了防晒产品的抗水成膜性差的问题。
6.本发明通过添加特定组分的保湿剂和乳化剂，改善了防晒产品的储存稳定性。并且意外发现当所述保湿剂为重量比3:0.08:4的甘油、透明质酸钠和乳酸钠复配以及所述乳化剂为水分散乳化剂，包括以下重量份组分：甘油硬脂酸酯1.1份，PEG-100硬脂酸酯0.9份，聚山梨醇酯-601份时，制备的防晒产品应用在痘痘肌和敏感肌上效果良好，不会产生过敏现象。本发明的防晒产品尤其适用于皮肤有破损的痘痘肌和敏感肌人群。
附图说明
图1Y-谷维素0.001g分别溶解到100mL的n-庚烷、乙醇、异丙醇中时的紫外线吸收曲线；
图2不同浓度的谷维素对不同波长的紫外吸收的影响，图A为随波长变化，图B为随浓度变化；
图3不同浓度的聚繖岩蔷薇提取物对不同波长的紫外吸收的影响，图A为随波长变化，图B为随浓度变化；
图4为实施例2制备的防晒产品对于UVA&蓝光防护的效果，图A为蓝光防护的效果，图B为UVA防护的效果；
图5是不同浓度实施例2制备的防晒产品对于角质细胞中Corneodesmosin含量的影响；
图6是实施例2制备的防晒产品对于透明质酸酶活性的抑制作用图；
图7是实施例2制备的防晒产品对于巨噬细胞炎症因子的降低效果图；
图8-9是实施例2制备的防晒产品对组胺炎症受试者的修复效果图。
图10为实施例2制备的防晒产品使用角质细胞测试，减少由UVB引起的炎症的效果图。
图11为聚繖岩蔷薇提取物对阻隔UVB诱导的细胞毒性的效果图，其中A为用麦芽糊精包裹的聚繖岩蔷薇提取物。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例，都属于本发明保护的范围。
实施例1
本实施例提供了植物来源的防晒增效组合物，包括以下重量份数的组分：谷维素0.08份、聚繖岩蔷薇提取物0.002份、鞘氨醇单胞菌发酵产物提取物0.05份和红没药醇0.15份。
本实施例提供了一种防晒产品，由以下重量份的组分组成，按100重量份计，包括所述的防晒增效组合物2份、奥克立林4份、双-乙基己氧苯酚甲氧苯基三嗪2份、乙基己基三嗪酮1.5份、二乙氨羟苯甲酰基苯甲酸己酯3份、胡莫柳酯5份、苯基苯并咪唑磺酸3份、二氧化钛7份、润肤剂29份、乳化剂3份、保湿剂3份、乙二胺四乙酸二钠0.03份、香精0.1份和防腐剂0.8份，余量为水。
所述润肤剂为重量比4:3.5:5的鲸蜡醇乙基己酸酯、异十六烷、丁基辛醇水杨酸酯复配。
所述保湿剂为重量比5:0.08:1的甘油、透明质酸钠和乳酸钠复配。
所述乳化剂为水分散乳化剂，包括以下重量份组分：甘油硬脂酸酯1.1份，PEG-100硬脂酸酯0.9份，聚山梨醇酯-601份。
所述防腐剂为：重量比9:1:的苯氧乙醇和乙基己基甘油。
本实施例提供了一种防晒产品的制备方法，包括以下步骤：
1)室温下将卡波姆、黄原胶、保湿剂、乙二胺四乙酸二钠、水分散乳化剂和水混合，再加热升温至80℃分散，保温10min，作为A相；
2)将奥克立林、谷维素、双-乙基己氧苯酚甲氧苯基三嗪、乙基己基三嗪酮、二乙氨羟苯甲酰基苯甲酸己酯、胡莫柳酯、二氧化钛、润肤剂和油分散乳化剂混合，加热升温至75～85℃溶解，保温10min，作为B相；
3)保温，将B相加入A相中乳化均质均匀，降温至57℃，再加入C相，加入pH中和剂(精氨酸、氨甲基丙醇或三乙醇胺)搅拌均匀；
4)搅拌降温至42℃，将香精、防腐剂、鞘氨醇单胞菌发酵产物提取物份和红没药醇混合，搅拌均质均匀；陈化过滤后得到所述防晒产品。
实施例2
本实施例与实施例1的区别为：包括以下重量份数的组分：谷维素0.05份、聚繖岩蔷薇提取物0.002份、鞘氨醇单胞菌发酵产物提取物0.06份和红没药醇0.2份。
对比例1
本对比例与实施例1的区别为：包括以下重量份数的组分：谷维素0.07份、聚繖岩蔷薇提取物0.01份、鞘氨醇单胞菌发酵产物提取物0.05份和红没药醇0.3份。
对比例2
本对比例与实施例1的区别为：一种防晒产品，由以下重量份的组分组成，按100重量份计，包括防晒增效组合物0.3份、奥克立林5份、双-乙基己氧苯酚甲氧苯基三嗪3份、乙基己基三嗪酮3份、二乙氨羟苯甲酰基苯甲酸己酯3份、胡莫柳酯5份、苯基苯并咪唑磺酸2份、二氧化钛3份、润肤剂27份、乳化剂3.5份、保湿剂8份、乙二胺四乙酸二钠0.05份、香精0.05份和防腐剂3份，余量为水。
对比例3
本对比例与实施例1的区别为：一种防晒产品，由以下重量份的组分组成，按100重量份计，包括防晒增效组合物0.5份、甲氧基肉桂酸乙基己酯8.5份、双-乙基己氧苯酚甲氧苯基三嗪2.5份、乙基己基三嗪酮3份、二乙氨羟苯甲酰基苯甲酸己酯3份、胡莫柳酯4份、二氧化钛4份、润肤剂25份、乳化剂3.3份、保湿剂7.5份、乙二胺四乙酸二钠0.03份、香精0.1份和防腐剂0.8份，余量为水。
对比例4
本对比例与实施例1的区别为：所述润肤剂为重量比2:1:1的鲸蜡醇乙基己酸酯、异十六烷、C12-15醇苯甲酸酯(CAS：68411-27-8)复配。
对比例5
本对比例与实施例1的区别为：所述保湿剂为质量比1:2:1的甘油、丙二醇和甘油聚醚-26复配。
对比例6
本对比例与实施例1的区别为：所述乳化剂为质量比0.2：1的水分散乳化剂和油分散乳化剂；所述水分散乳化剂为聚甘油-10月桂酸酸酯；所述油分散乳化剂为月桂基PEG-9聚二甲基硅氧乙基聚二甲基硅氧烷。
性能测试
1、人体皮肤斑贴试验
样品：实施例和对比例制备的防晒产品，市售防晒产品苏菲娜、去离子水和空白作为对照。
试验依据
《化妆品安全技术规范》2015版
《化妆品卫生规范》2007版
方法：本次测试总共招募30名志愿者，年龄22～53岁，无中途退出人员，总有效人数数据为30人。实验员依次将受试物用移液枪注入斑试器内，用量为0.020～0.025g，受试物为化妆品终产品原物时，对照孔为空白对照(不置任何物质)。将加有受试物的斑试器用无刺激胶带贴敷于受试者的前臂曲侧(离手腕3指宽)，用手掌轻压使之均匀地贴敷于皮肤上，持续24h。去除受试物斑试器后30min，待压痕消失后观察皮肤反应，24h和48h分别再观察一次。统计不同评分等级人数，结果见表3。
试验耗材
斑试器(北京百忆怡达科技)，圆形，内径7mm，深度约1mm；移液器micromanE M100E(吉而逊实验仪器有限公司)。
测试指标
根据2015版《化妆品安全技术规范》规定的皮肤不良反应分级标准。见表1、表2。
表1结果判定要求
表2皮肤不良反应分级标准
表3人体皮肤斑贴试验
2、抗水成膜性试验
选择健康、无皮肤病、手臂前端光洁的30名志愿者，年龄范围为22～53岁。采用前后对照的方法，在试验还测试前，上样后20分钟、冲洗后20分钟分别对受试者手臂前端进行脱妆程度评分。志愿者测试当天1-3h不能接触水，志愿者统一用干的面巾纸擦拭双手前臂内侧，志愿者前臂内侧标记2cm×2cm的测试区域，同一手臂标记8个区域，每个测试区域之间间隔至少1cm。测定实施例和对比例的抗水成膜性。总分为10分，分数越高、性能越好，求平均值，结果见表4。
3、稳定性试验
将实施例和对比例分别置于以下4种环境进行观察，测试实施例和对比例的料体稳定性。结果见表4。
常温：样品在25℃，60％RH(相对湿度)静置30天。
耐寒：-10℃放置10天。
冷热循环：-10℃，25％RH；25℃，60％RH；38℃，75％RH，每个温度24h，共6个循环。
高温加速：测试条件为50℃±1℃，25％RH±5％RH放置30天。
4、采用防晒指数测定仪，分别测实施例和对比例制得的防晒产品的防晒值，结果见表4。
表4测定结果
通过结果可知，本发明制备的防晒产品防晒性、成模性、防水性、稳定性佳。本发明的防晒组合物0.1％，使用角质细胞测试，减少由UVB引起的炎症。
以上所述是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明所述原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。
Claims (2)
1.一种水包油防晒产品，其特征在于，由以下重量份的组分组成，按100重量份计，包括防晒增效组合物0.5-5份、奥克立林1-5份、双-乙基己氧苯酚甲氧苯基三嗪0.5-5份、乙基己基三嗪酮0.5-5份、二乙氨羟苯甲酰基苯甲酸己酯0.5-5份、胡莫柳酯1-10份、苯基苯并咪唑磺酸1-5份、二氧化钛2-10份、润肤剂10-30份、乳化剂0.5-3份、保湿剂1-6份、乙二胺四乙酸二钠0.01-0.3份、香精0.01-0.5份和防腐剂0.1-2份，余量为水；其中，防晒增效组合物包括以下重量份数的组分：谷维素0.001-1份、聚繖岩蔷薇提取物0.001-0.5份、鞘氨醇单胞菌发酵产物提取物0.001-0.5份和红没药醇0.001-0.2份；谷维素、聚繖岩蔷薇提取物、鞘氨醇单胞菌发酵产物提取物和红没药醇的重量比为1：0.02-5：0.2-10.0：1-20.0；
所述润肤剂为重量比4:3-4:4-6的鲸蜡醇乙基己酸酯、异十六烷、丁基辛醇水杨酸酯复配；
所述保湿剂为甘油、透明质酸钠和乳酸钠复配；
所述乳化剂为水分散乳化剂，包括以下重量份组分：1.1份甘油硬脂酸酯，0.9份PEG-100硬脂酸酯，1份聚山梨醇酯-60。
2.根据权利要求1所述的防晒产品，其特征在于，所述防腐剂为重量比9:1:的苯氧乙醇和乙基己基甘油。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311496013.8A CN117503626B (zh) | 2023-11-09 | 2023-11-09 | 植物来源的防晒增效组合物、防晒产品、制备方法和应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311496013.8A CN117503626B (zh) | 2023-11-09 | 2023-11-09 | 植物来源的防晒增效组合物、防晒产品、制备方法和应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117503626A CN117503626A (zh) | 2024-02-06 |
| CN117503626B true CN117503626B (zh) | 2024-04-16 |
Family
ID=89756200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311496013.8A Active CN117503626B (zh) | 2023-11-09 | 2023-11-09 | 植物来源的防晒增效组合物、防晒产品、制备方法和应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117503626B (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003300860A (ja) * | 2002-02-05 | 2003-10-21 | Kose Corp | 皮膚外用剤 |
| JP2007326797A (ja) * | 2006-06-07 | 2007-12-20 | Nakano Seiyaku Kk | 化粧料 |
| CN106176377A (zh) * | 2016-08-08 | 2016-12-07 | 珀莱雅化妆品股份有限公司 | 一种植物来源的防晒增效组合物及其制备方法 |
| CN111821235A (zh) * | 2020-07-13 | 2020-10-27 | 植物医生(广东)生物科技有限公司 | 一种光保护植物提取组合物及其应用 |
| WO2021102874A1 (en) * | 2019-11-29 | 2021-06-03 | Beiersdorf Daily Chemical (Wuhan) Co., Ltd. | An oil-in-water sunscreen composition |
| CN113164797A (zh) * | 2018-12-21 | 2021-07-23 | 巴斯夫美容护理法国公司 | 聚伞岩蔷薇提取物的新型化妆品和皮肤病学用途 |
| CN116139064A (zh) * | 2023-04-17 | 2023-05-23 | 广州集妍化妆品科技有限公司 | 一种防晒增效组合物及其应用和化妆品 |
-
2023
- 2023-11-09 CN CN202311496013.8A patent/CN117503626B/zh active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003300860A (ja) * | 2002-02-05 | 2003-10-21 | Kose Corp | 皮膚外用剤 |
| JP2007326797A (ja) * | 2006-06-07 | 2007-12-20 | Nakano Seiyaku Kk | 化粧料 |
| CN106176377A (zh) * | 2016-08-08 | 2016-12-07 | 珀莱雅化妆品股份有限公司 | 一种植物来源的防晒增效组合物及其制备方法 |
| CN113164797A (zh) * | 2018-12-21 | 2021-07-23 | 巴斯夫美容护理法国公司 | 聚伞岩蔷薇提取物的新型化妆品和皮肤病学用途 |
| WO2021102874A1 (en) * | 2019-11-29 | 2021-06-03 | Beiersdorf Daily Chemical (Wuhan) Co., Ltd. | An oil-in-water sunscreen composition |
| CN111821235A (zh) * | 2020-07-13 | 2020-10-27 | 植物医生(广东)生物科技有限公司 | 一种光保护植物提取组合物及其应用 |
| CN116139064A (zh) * | 2023-04-17 | 2023-05-23 | 广州集妍化妆品科技有限公司 | 一种防晒增效组合物及其应用和化妆品 |
Non-Patent Citations (1)
| Title |
|---|
| 谷维素的研究进展;刘瑞菊;褚建波;陈启云;;河南科技大学学报(医学版);20150925(第03期);第237-240页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117503626A (zh) | 2024-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20100129689A (ko) | 함수 또는 흡습 제제와 조합하여 항산화제로서 폴리페놀이 풍부한 식물 추출물의 용도 | |
| CN110946784A (zh) | 一种具有提升皮肤屏障功能、加强皮肤健康的护肤组合物 | |
| KR101458887B1 (ko) | 히카마, 콜리플라워, 말로우 및 아이슬란드 이끼 천연 복합추출물을 유효성분으로 함유하는 항산화, 보습, 피부 자극 완화 효과를 갖는 피부 개선용 화장료 조성물 | |
| CN111714389A (zh) | 一种复合防晒剂、防晒化妆品及其制备方法 | |
| CN113693990A (zh) | 一种用于有效抗氧化保湿的组合物及其制备方法与用途 | |
| CN110292543B (zh) | 一种替代紫外线吸收剂的生物组合物及其应用 | |
| CN115252510A (zh) | 一种防晒组合物及其应用 | |
| KR100992088B1 (ko) | 자외선 차단 효과를 제공하는 천연 식물 추출물을 함유한 화장료 조성물 | |
| CN112516022B (zh) | 一种防晒露及其制备方法 | |
| CN108014060B (zh) | 一种防晒增效组合物及其应用 | |
| KR100984163B1 (ko) | 차요테 추출물을 함유하는 보습용 화장료 조성물 및 이의 제조방법 | |
| CN116139064B (zh) | 一种防晒增效组合物及其应用和化妆品 | |
| CN117503626B (zh) | 植物来源的防晒增效组合物、防晒产品、制备方法和应用 | |
| CN113384510B (zh) | 一种具有抗光老化、舒缓清凉功效的发酵组合物及其制备方法和应用 | |
| CN112870122B (zh) | 一种具有光防护功效的高稳定性纳米乳液及其制备方法 | |
| KR20120038321A (ko) | 아피오스를 이용한 화장료 조성물 및 이의 제조방법 | |
| KR20150106244A (ko) | 자외선 차단 및 보습용 화장품 조성물 | |
| KR102169463B1 (ko) | 피부트러블 개선용 화장료 조성물 | |
| CN110604716B (zh) | 一种光防护植物组合物及其制备方法和应用 | |
| CN113730269A (zh) | 一种温和、具有防晒功效的凝胶及其制备方法 | |
| KR20180124443A (ko) | 흰목이버섯 자실체 추출물을 포함하는 피부장벽강화용 화장료 조성물 | |
| KR20090068397A (ko) | 두피 보호 및 피부 진정 효과를 가지는 화장료 조성물 | |
| KR102067698B1 (ko) | 가공한 인삼 및 녹차에서 추출한 다당체를 함유하는 미백용 및 자외선 차단용 조성물 | |
| CN114748406B (zh) | 一种舒缓保湿护肤水及其制备方法 | |
| KR101603956B1 (ko) | 그린 토마토 뽕나무버섯 발효추출물을 유효성분으로 함유하는 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |